PSC
BGMD

Prentiss Smith & Co’s BG MEDICINE INC COM STK NEW BGMD Stock Holding History

Prentiss Smith & Co’s Portfolio BGMD Stock Details BGMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-1,250
Closed -$3K – 365
2015
Q2 		$3K Hold
1,250
– – ﹤0.01% 274
2015
Q1 		$4K Hold
1,250
– – ﹤0.01% 281
2014
Q4 		$2K Hold
1,250
– – ﹤0.01% 306
2014
Q3 		$3K Hold
1,250
– – ﹤0.01% 224
2014
Q2 		$5K Hold
1,250
– – ﹤0.01% 214
2014
Q1 		$10K Buy
+1,250
New +$6.91K 0.01% 207

Other funds holding BGMD

AP
AGTC Partners Cambridge, Massachusetts $13.6M AUM 15.62% 1-Year Est. Return
FV2GP
Flagship Ventures 2007 General Partner Cambridge, Massachusetts $107M AUM

Prentiss Smith & Co's BGMD Position: Q3 2015 in Review

Prentiss Smith & Co sold out of BG MEDICINE INC COM STK NEW (BGMD) in Q3 2015, closing a stake of 1,250 shares — an estimated $3K sold.

Prentiss Smith & Co first reported a position in BGMD in Q1 2014 and held it in 6 quarters. The position peaked at $10K in Q1 2014. 2 funds tracked by Wall St. Rank hold BGMD as of Q3 2015.

  • Prentiss Smith & Co reported no remaining BG MEDICINE INC COM STK NEW position as of Q3 2015 after selling out during the quarter.
  • Prentiss Smith & Co sold 1,250 BG MEDICINE INC COM STK NEW shares in Q3 2015, an estimated $3K.
  • Prentiss Smith & Co first reported a position in BG MEDICINE INC COM STK NEW in Q1 2014 and held it in 6 quarters.
  • Prentiss Smith & Co's BG MEDICINE INC COM STK NEW position peaked at $10K in Q1 2014.
  • 2 funds tracked by Wall St. Rank held BG MEDICINE INC COM STK NEW as of Q3 2015.

Based on Prentiss Smith & Co's 13F filing for Q3 2015, filed 26 Oct 2015.